Alkaptonuria

Results: 11



#Item
1THE INCIDENCE OF ALKAPTONURIA: A STUDY IN CHEMICAL INDIVIDUALITY ARCHIBALD E. GARROD Physician to the Hospital for Sick Children, Great Ormondstreet, Demonstrator of Chemical Pathology at St. Bartholemew’s Hospital

THE INCIDENCE OF ALKAPTONURIA: A STUDY IN CHEMICAL INDIVIDUALITY ARCHIBALD E. GARROD Physician to the Hospital for Sick Children, Great Ormondstreet, Demonstrator of Chemical Pathology at St. Bartholemew’s Hospital

Add to Reading List

Source URL: www.esp.org

Language: English - Date: 2010-05-11 22:25:54
    2Statement of Principles concerning ALKAPTONURIA No. 47 of 2007 for the purposes of the

    Statement of Principles concerning ALKAPTONURIA No. 47 of 2007 for the purposes of the

    Add to Reading List

    Source URL: www.rma.gov.au

    Language: English - Date: 2014-05-06 01:36:09
    3Statement of Principles concerning ALKAPTONURIA No. 48 of 2007 for the purposes of the

    Statement of Principles concerning ALKAPTONURIA No. 48 of 2007 for the purposes of the

    Add to Reading List

    Source URL: www.rma.gov.au

    Language: English - Date: 2014-05-06 01:36:09
    4“First Scientific Workshop on Fundamental Diseases” Sidney Sussex College, Cambridge, CB2 3HU 14th March, 1.30—5.30pm 1:30 – 2:00

    “First Scientific Workshop on Fundamental Diseases” Sidney Sussex College, Cambridge, CB2 3HU 14th March, 1.30—5.30pm 1:30 – 2:00

    Add to Reading List

    Source URL: www.findacure.org.uk

    Language: English - Date: 2013-12-17 06:42:11
    5A new cause of osteoarthritis identified by research on a rare disease

    A new cause of osteoarthritis identified by research on a rare disease

    Add to Reading List

    Source URL: medicalxpress.com

    Language: English - Date: 2014-12-02 22:58:11
    6Board of Directors Chairman Clyde Hammond . Summit Laboratories, Inc . 1 st Vice-Chairman Michael W. Joshua

    Board of Directors Chairman Clyde Hammond . Summit Laboratories, Inc . 1 st Vice-Chairman Michael W. Joshua

    Add to Reading List

    Source URL: www.fda.gov

    Language: English - Date: 2007-03-20 08:53:59
    7HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Orfadin safely and effectively. See full prescribing information for Orfadin. ORFADIN® (nitisinone) capsules Initia

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Orfadin safely and effectively. See full prescribing information for Orfadin. ORFADIN® (nitisinone) capsules Initia

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2013-02-14 16:20:43
    8NIH Public Access Author Manuscript Mol Genet Metab. Author manuscript; available in PMC 2012 August 1. NIH-PA Author Manuscript

    NIH Public Access Author Manuscript Mol Genet Metab. Author manuscript; available in PMC 2012 August 1. NIH-PA Author Manuscript

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    9Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery

    Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English
    10ISSN[removed] © Am J Case Rep, 2014; 15: 27-30 DOI: [removed]AJCR[removed]Received: [removed]Accepted: [removed]Published: [removed]

    ISSN[removed] © Am J Case Rep, 2014; 15: 27-30 DOI: [removed]AJCR[removed]Received: [removed]Accepted: [removed]Published: [removed]

    Add to Reading List

    Source URL: www.ncbi.nlm.nih.gov

    Language: English